Arthritispainselfhelp.com News
Y! Health Arthritis News
Y! Health Arthritis News, updated continuously.
High Birth Weight Doubles Risk of Rheumatoid Arthritis (HealthDay)
HealthDay - MONDAY, June 30 (HealthDay News) -- The risk of rheumatoid arthritis is
twice as high in women who had a heavy birth weight (more than 10 pounds)
than those with an average birth weight (7 to 8.5 lbs), a new study
finds.
Heavy babies prone to arthritis as adults (Reuters)
Reuters - People who were heavier than
average when they were born appear to be twice as likely to
develop rheumatoid arthritis as their normal birth-weight
counterparts, researchers report.
Hip Replacement Boosts Mobility at Any Age (HealthDay)
HealthDay - FRIDAY, June 27 (HealthDay News) -- Total hip replacements are
beneficial and economical for seniors with osteoarthritis, regardless of
their age, say researchers at Duke University Medical Center.
Rheumatoid Arthritis Treatment Guidelines Updated (HealthDay)
HealthDay - THURSDAY, June 26 (HealthDay News) -- New recommendations for the use
of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of
rheumatoid arthritis (RA) have been developed by the American College of
Rheumatology.
Rheumatoid Arthritis Drug Boosts Melanoma Incidence (HealthDay)
HealthDay - FRIDAY, June 20 (HealthDay News) -- Rheumatoid arthritis (RA)
patients treated with methotrexate have an increased incidence of melanoma
and other cancers, an Australian study says.
FDA Panel Recommends Enbrel for Pediatric Patients (HealthDay)
HealthDay - WEDNESDAY, June 18 (HealthDay News) -- A U.S. Food and Drug
Administration advisory panel recommended Wednesday that the psoriasis
drug Enbrel be approved for use in children who have moderate-to-severe
forms of the skin disease.
Rheumatoid arthritis said to double heart risk (Reuters)
Reuters - People with rheumatoid arthritis have
double the risk of suffering heart attacks or strokes and
should be considered for treatment with statins and blood
pressure drugs, rheumatology experts said on Friday.
Cimzia reduces arthritis joint damage at 16 wks (Reuters)
Reuters - Cimzia stops structural damage to joints
in patients with rheumatoid arthritis as soon as 16 weeks after
the start of treatment, according to new data presented on
Thursday.
Golimumab Eases Rheumatoid Arthritis Symptoms (HealthDay)
HealthDay - WEDNESDAY, June 11 (HealthDay News) -- Adding monthly injections
of golimumab to weekly doses of methotrexate helped most people with
rheumatoid arthritis, even putting some into remission, two new studies
show.
J&J, Schering arthritis drug effective in trials (Reuters)
Reuters - An experimental treatment for
rheumatoid arthritis being developed by Johnson & Johnson and
Schering-Plough Corp appeared to be effective and very safe in
three late-stage trials, the companies said on Tuesday.
|
